Key Clinical Message:
Rare, aggressive primary vaginal melanoma presents late with bleeding
and palpable masses. Histology and immunohistochemistry confirm the
diagnosis. Nivolumab and Ipilimumab offer hope in advanced stages. Early
diagnosis is critical for better outcomes.